ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction

Abstract Cancer has become a major factor threatening human life and health. Under the circumstance that traditional treatment methods such as chemotherapy and radiotherapy are not highly specific and often cause severe side effects and toxicity, new treatment methods are urgently needed. Anticancer...

Full description

Bibliographic Details
Main Authors: Bingqing Han, Nan Zhao, Chengshi Zeng, Zengchao Mu, Xinqi Gong
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-24404-1
_version_ 1797977501654319104
author Bingqing Han
Nan Zhao
Chengshi Zeng
Zengchao Mu
Xinqi Gong
author_facet Bingqing Han
Nan Zhao
Chengshi Zeng
Zengchao Mu
Xinqi Gong
author_sort Bingqing Han
collection DOAJ
description Abstract Cancer has become a major factor threatening human life and health. Under the circumstance that traditional treatment methods such as chemotherapy and radiotherapy are not highly specific and often cause severe side effects and toxicity, new treatment methods are urgently needed. Anticancer peptide drugs have low toxicity, stronger efficacy and specificity, and have emerged as a new type of cancer treatment drugs. However, experimental identification of anticancer peptides is time-consuming and expensive, and difficult to perform in a high-throughput manner. Computational identification of anticancer peptides can make up for the shortcomings of experimental identification. In this study, a deep learning-based predictor named ACPred-BMF is proposed for the prediction of anticancer peptides. This method uses the quantitative and qualitative properties of amino acids, binary profile feature to numerical representation for the peptide sequences. The Bidirectional LSTM network architecture is used in the model, and the attention mechanism is also considered. To alleviate the black-box problem of deep learning model prediction, we visualized the automatically extracted features and used the Shapley additive explanations algorithm to determine the importance of features to further understand the anticancer peptide mechanism. The results show that our method is one of the state-of-the-art anticancer peptide predictors. A web server as the implementation of ACPred-BMF that can be accessed via: http://mialab.ruc.edu.cn/ACPredBMFServer/ .
first_indexed 2024-04-11T05:07:56Z
format Article
id doaj.art-ceb97960cb59456e8592e132667a4c14
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T05:07:56Z
publishDate 2022-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-ceb97960cb59456e8592e132667a4c142022-12-25T12:13:49ZengNature PortfolioScientific Reports2045-23222022-12-0112111610.1038/s41598-022-24404-1ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide predictionBingqing Han0Nan Zhao1Chengshi Zeng2Zengchao Mu3Xinqi Gong4Institute for Mathematical Sciences, Renmin University of ChinaInstitute for Mathematical Sciences, Renmin University of ChinaInstitute for Mathematical Sciences, Renmin University of ChinaSchool of Mathematics and Statistics, Shandong UniversityInstitute for Mathematical Sciences, Renmin University of ChinaAbstract Cancer has become a major factor threatening human life and health. Under the circumstance that traditional treatment methods such as chemotherapy and radiotherapy are not highly specific and often cause severe side effects and toxicity, new treatment methods are urgently needed. Anticancer peptide drugs have low toxicity, stronger efficacy and specificity, and have emerged as a new type of cancer treatment drugs. However, experimental identification of anticancer peptides is time-consuming and expensive, and difficult to perform in a high-throughput manner. Computational identification of anticancer peptides can make up for the shortcomings of experimental identification. In this study, a deep learning-based predictor named ACPred-BMF is proposed for the prediction of anticancer peptides. This method uses the quantitative and qualitative properties of amino acids, binary profile feature to numerical representation for the peptide sequences. The Bidirectional LSTM network architecture is used in the model, and the attention mechanism is also considered. To alleviate the black-box problem of deep learning model prediction, we visualized the automatically extracted features and used the Shapley additive explanations algorithm to determine the importance of features to further understand the anticancer peptide mechanism. The results show that our method is one of the state-of-the-art anticancer peptide predictors. A web server as the implementation of ACPred-BMF that can be accessed via: http://mialab.ruc.edu.cn/ACPredBMFServer/ .https://doi.org/10.1038/s41598-022-24404-1
spellingShingle Bingqing Han
Nan Zhao
Chengshi Zeng
Zengchao Mu
Xinqi Gong
ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction
Scientific Reports
title ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction
title_full ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction
title_fullStr ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction
title_full_unstemmed ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction
title_short ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction
title_sort acpred bmf bidirectional lstm with multiple feature representations for explainable anticancer peptide prediction
url https://doi.org/10.1038/s41598-022-24404-1
work_keys_str_mv AT bingqinghan acpredbmfbidirectionallstmwithmultiplefeaturerepresentationsforexplainableanticancerpeptideprediction
AT nanzhao acpredbmfbidirectionallstmwithmultiplefeaturerepresentationsforexplainableanticancerpeptideprediction
AT chengshizeng acpredbmfbidirectionallstmwithmultiplefeaturerepresentationsforexplainableanticancerpeptideprediction
AT zengchaomu acpredbmfbidirectionallstmwithmultiplefeaturerepresentationsforexplainableanticancerpeptideprediction
AT xinqigong acpredbmfbidirectionallstmwithmultiplefeaturerepresentationsforexplainableanticancerpeptideprediction